Skip to main content

Table 4 Multivariable logistic regressive analysis: risk factors for flare in SACQ

From: Treatments and outcomes in Chinese patients with serologically active clinically quiescent systemic lupus erythematosus: a retrospective observational study

  β p OR (95% CI)
Dose of corticosteroidsa (mg) when relapsed or at the end of follow-up 0.280 0.001 1.323 (1.129, 1.550)
Taking antimalarials when relapsed or at the end of follow-up − 3.105 0.010 0.045 (0.004, 0.474)
Taking immunosuppressants when relapsed or at the end of follow-up − 1.102 0.004 0.332 (0.156, 0.706)
  1. Variables included in the model: dose of corticosteroids (mg) when relapsed or at the end of follow-up, taking antimalarials when relapsed or at the end of follow-up, taking immunosuppressants when relapsed or at the end of follow-up, duration of serological activity before SACQ (months), anti-dsDNA (+), and/or hypocomplementemia
  2. aCorticosteroid doses were converted to milligrams (mg) of prednisone equivalent